AI-Powered Low-Dose CT could spare cancer patients unnecessary radiation
NCT ID NCT03151564
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a low-radiation CT scan, enhanced with artificial intelligence software, can detect liver tumors as accurately as a standard CT scan. About 146 adults with colorectal cancer and known liver metastases will receive both scans. The goal is to see if the lower-dose method provides clear enough images for radiologists to find tumors, potentially reducing radiation exposure in future scans.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple blood draw could spot colorectal cancer early
- A new test could reveal how radiation affects the liver
- Can a Cancer-Fighting virus shrink tumors when chemo fails?
- A new clue in the fight against colorectal cancer recurrence?
- AI-Powered app aims to transform colorectal cancer recovery monitoring
- A new way to read CT scans may predict which liver surgery patients will develop Life-Threatening failure